Genesis Bioventures, Inc. Announces Filing of 8K for Investment From Firebird Global Master Fund II, Ltd. Feb 9, 2007
Source: Genesis Bioventures ... Feb. 8, 2007 (PRIME NEWSWIRE) -- Genesis Bioventures, Inc. (OTC BB: - ), a biomedical development corporation focusing on the development and commercialization of novel diagnostics and therapeutics in oncology and neurodegenerative diseases, announced today that on December 29, 2006 it entered into an investment from Firebird Global Master Fund II, Ltd, (``Firebird'') ... Genesis Bioventures, Inc. believes the sale of the Note, issuance of the shares of common... (Primezone Releases)
Genesis Bioventures Announces Agreement to Manufacture Mad Cow Disease Rapid Assay Test Kits Oct 10, 2006
Source: Genesis Bioventures ... NEW YORK, Oct. 10, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTC BB: - ) announced today that Prion Developmental Laboratories (``PDL''), its minority owned subsidiary company, entered into a contract manufacturing agreement with InBios International, Inc. (``InBios''), a leading biotechnology company in Seattle, Washington, to manufacture PDL's Mad Cow Disease (``BSE'') and other TSE Rapid Diagnostic Tests ... This is an important step in our... (Primezone Releases)
Genesis Bioventures Extends Prion Developmental Laboratories Acquisition Letter of Intent Sep 12, 2006
Source: Genesis BioVentures ... NEW YORK, Sept. 11, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTC BB: - ) today announced that the Company and Prion Developmental Laboratories (``PDL'') mutually agreed on August 30, 2006 to extend the non-binding acquisition Letter of Intent for an additional sixty days ... Genesis Bioventures learned on July 27, 2006 that a court ordered ``freeze order'' obtained by the SEC against Efoora Inc. (``Efoora'') assets, after the SEC filed a civil... (Primezone Releases)
Genesis Bioventures to Present at the National Investment Banking Association's Capital Conference Sep 12, 2006
Source: Genesis BioVentures ... NEW YORK, Sept. 11, 2006 (PRIMEZONE) -- Genesis Bioventures, Inc. (GBI) (OTC BB: - ) today announced that its President and CEO, Mr. Douglas C. Lane, will present the newly restructured Genesis Bioventures at the National Investment Banking Association's (NIBA) Capital Conference on September 14th and 15th at the Wyndham Chicago Hotel in Chicago, IL. ... We are very pleased to have the opportunity to present the newly restructured Genesis Bioventures, Inc. to the... (Primezone Releases)
RedChip Visibility Initiates Research on Genesis Bioventures, Inc. Aug 14, 2006
Source: RedChip Companies Inc.; Genesis Bioventures, Inc. ... Aug. 14, 2006 (PRIMEZONE) -- RedChip Visibility, a division of RedChip Companies, announced today that they have initiated research on Genesis Bioventures, Inc. (OTC BB: - ) ... RedChip Companies Inc. is an affiliate of the Aurelius Consulting Group, Inc. Genesis Bioventures, Inc. is a client of the Aurelius Consulting Group, Inc. and of RedChip Visibility, a division of RedChip Companies. (Primezone Releases)
Forty Companies Representing Thirty Industries Set to Present at the RedChip Small-Cap Conference in New York, August 15-16, 2006 Aug 14, 2006
Aug. 14, 2006 (PRIMEZONE) -- RedChip Visibility, a division of RedChip Companies, announced today that Electronic Sensor Technology (OTC BB: - ), Black Dragon Resources Inc. (Other OTC: - ), Genesis Bioventures Inc. (OTC BB: - ), Innofone. com Inc. (OTC BB: - ), VoIP Inc. (OTC BB: - ), QPC Lasers Inc. (OTC BB: - ), Drinks Americas Holdings, Ltd. (OTC BB: - ), Left Behind Games Inc. (OTC BB: - ), and thirty more will present at the RedChip Small-Cap Investor Conference at the Avenue of Americas... (Primezone Releases)
